Michael J Panigot

Title: The Innovative Contributions of Michael J. Panigot

Introduction

Michael J. Panigot, based in Columbus, OH, is a notable inventor with significant contributions to the field of biomedical innovations. With a focus on breast cancer chemoprevention, Panigot has developed advanced arylamide analogues that hold promise for improving therapeutic outcomes in cancer treatment.

Latest Patents

Panigot holds two patents that delve into the formulation of C-glycoside analogues of N-(4-hydroxyphenyl) retinamide-O-glucuronide. These innovative drugs, designed to resist both β-glucuronidase mediated enzymatic hydrolysis and acid-catalyzed hydrolysis, include formulations such as 4-(retinamido)phenyl-C-glucuronide, 4-(retinamido)phenyl-C-glucoside, 4-(retinamido)benzyl-C-xyloside, 4-(retinamido)benzyl-C-glucoside, 4-(retinamido)benzyl-C-glucuronide, and 4-(retinamido)phenyl-C-xyloside. These patents reflect Panigot's commitment to advancing cancer treatment methodologies through innovative chemical formulations.

Career Highlights

Currently, Michael J. Panigot is associated with the Ohio State Research Foundation, where his research focuses on developing cutting-edge solutions in the realm of cancer prevention and treatment. His career is marked by a dedication to enhancing the efficacy of existing therapeutic modalities while introducing novel compounds that could revolutionize patient care.

Collaborations

In his endeavors, Panigot collaborates closely with Robert W. Curley, Jr., a fellow researcher whose expertise complements Panigot's goals. Their joint efforts contribute to a thriving research environment aimed at tackling complex health challenges through innovation.

Conclusion

Michael J. Panigot stands out in the field of oncology innovation with his substantial contributions to breast cancer chemoprevention. His patents not only showcase his inventive capabilities but also highlight the importance of collaborative research in advancing healthcare solutions. With ongoing research and development, Panigot's work has the potential to significantly impact the future of cancer therapies.